The Lancet: UK-US post-Brexit trade deal risks increased drug prices, and may threaten the NHS
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, United Kingdom, North America, United States
Keywords: Health, People in health research, Policy, Public Dialogue - health, Business, Medical & pharmaceutical
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.